Evaluation of clinical relationship of serum niacin and dopamine levels in patients with fibromyalgia syndrome
Yazarlar (3)
Doç. Dr. Muzaffer KATAR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Arş. Gör. Hülya Deveci Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Köksal DEVECİ Tokat Gaziosmanpaşa Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | Turkish Journal of Physical Medicine and Rehabilitation (Q4) | ||
| Dergi ISSN | 2587-1250 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 03-2022 |
| Cilt / Sayı / Sayfa | 68 / 1 / 84–90 | DOI | 10.5606/tftrd.2022.8529 |
| Makale Linki | http://www.ftrdergisi.com/uploads/pdf/pdf_4311.pdf | ||
| UAK Araştırma Alanları |
Tıbbi Biyokimya
|
||
| Özet |
| Objectives The aim of this study was to investigate the role of serum niacin and dopamine (DA) levels and their clinical importance in fibromyalgia syndrome (FMS) patients. Patients and methods Between April 2018 and October 2018, a total of 53 female patients (mean age: 38.3±5.5 years; range, 21 to 45 years) with a clinical diagnosis of FMS and 35 healthy female controls (mean age: 36.7±5.2 years; range, 25 to 44 years) were included in this cross-sectional study. The Visual Analog Scale (VAS), Beck Depression Inventory (BDI), and Fibromyalgia Impact Questionnaire (FIQ) were applied to the patients. Serum levels of niacin and DA were measured by high-performance liquid chromatography (HPLC) and enzyme-linked immunosorbent assay (ELISA) methods, respectively. Results Niacin and DA levels of the patient group were significantly lower than those of control group (p=0.003 and p=0.02, respectively … |
| Anahtar Kelimeler |
| Dopamine | Fibromyalgia syndrome | Niacin | Pain | Point number | Tender |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Scopus | 7 |
| Google Scholar | 8 |